BRMS1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BRMS1 Antibodies for advanced research in the field of cancer biology and metastasis. BRMS1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRMS1, or Breast Cancer Metastasis Suppressor 1, plays a critical role in inhibiting the metastatic spread of breast cancer cells, making it a significant focus for understanding cancer progression and treatment. By regulating gene expression and influencing cellular pathways, BRMS1 contributes to the suppression of tumor growth and metastasis. Researchers worldwide utilize BRMS1 monoclonal antibodies to investigate cellular signaling pathways involved in cancer development. Advanced detection methods, including fluorescein isothiocyanate (FITC), phycoerythrin (PE), and horseradish peroxidase (HRP) conjugates, enable precise visualization and quantification of BRMS1 expression patterns. Understanding BRMS1's role in cancer biology opens new avenues for developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies support the scientific community's efforts to advance cancer research and develop innovative therapeutic strategies.